Autoimmunity

Biography

Sylviane Muller received her doctoral degrees in Molecular Biology (1978) and Science (1984) from the University of Strasbourg (France). She worked as a post-doctoral fellow at the Max-Planck Institute for Immunobiology in Freiburg (Germany). She is currently Distinguished class Research Director at the CNRS and Professor at the Institute of Advanced Studies of the Strasbourg University (chair Therapeutic immunology). She is deputy director of the Molecular and Cellular Biology Institute, Director of the CNRS Unit Immunopathology and therapeutic chemistry, and Head of the Drug discovery center for cancer and inflammation Medalis awarded 'Laboratory of Excellence’. Her research interests focus on molecular and cellular events involved in autoimmunity, especially in the lupus disease. She discovered the P140/Lupuzor peptide that is currently evaluated in a phase III clinical trial for lupus. She is the co-author of over 345 publications, co-inventor of ~30 patents and co-founder of NeoMPS (1986) and ImmuPharma (2002) companies. She received the CNRS Silver Medal (2009) and the CNRS Innovation Award (2015).

Research Interest

molecular and cellular events involved in autoimmunity, especially in the lupus disease. She discovered the P140/Lupuzor peptide that is currently evaluated in a phase III clinical trial for lupus